Browse (660.42 kB)

Download (660.42 kB) This item is shared privately
modified on 2017-03-30, 19:47
This file consists of the data set used to reach the conclusions drawn in the manuscript "Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis". The applied methods can be found in the manuscript. The study was approved by the ethics committee of the Hamburg Chamber of Physicians (PV3983 10.4.2012 and PV3955 5.1.2012).